Glucose Health, Inc.
GLUC · OTC
9/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.23 | 0.26 | 0.32 |
| FCF Yield | 0.00% | -1.26% | -3.32% | -5.78% |
| EV / EBITDA | -16.71 | -26.63 | -36.23 | -40.98 |
| Quality | ||||
| ROIC | 54.06% | -90.56% | -37.15% | -39.13% |
| Gross Margin | -0.23% | 20.50% | 26.08% | -34.30% |
| Cash Conversion Ratio | 0.27 | 1.08 | 2.01 | 1.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -28.19% | -29.62% | -26.49% | -24.95% |
| Free Cash Flow Growth | 0.00% | 71.56% | 69.12% | -133.05% |
| Safety | ||||
| Net Debt / EBITDA | -3.19 | -3.50 | -3.34 | -1.32 |
| Interest Coverage | -6.08 | -11.94 | -11.18 | -25.70 |
| Efficiency | ||||
| Inventory Turnover | 0.42 | 0.27 | 0.18 | 0.40 |
| Cash Conversion Cycle | 150.02 | 304.74 | 488.64 | 234.74 |